When making important decisions about disease prevention, who do you listen to? Medical institutions? Or perhaps the people around you? Your answer might reveal more about your personal circumstances than you would expect.
Novo raises 2023 outlook due to higher than expected Ozempic and Wegovy sales in the US
Novo Nordisk is raising its sales and operating profit estimates for the year thanks to its diabetes and anti-obesity semaglutide products Wegovy and Ozempic, the
October 14, 2023